Dynamic Technology Lab Private LTD Esperion Therapeutics, Inc. Transaction History

Dynamic Technology Lab Private LTD

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$1.84 - $3.24 $31,292 - $55,102	17,007 New	17,007 $38,000
Q1 2023 May 12, 2023	BUY	$1.46 - $7.3 $30,581 - $152,905	20,946 Added 132.97%	36,699 $58,000
Q4 2022 Feb 13, 2023	BUY	$5.09 - $8.5 $80,182 - $133,900	15,753 New	15,753 $98,000
Q2 2022 Aug 12, 2022	SELL	$4.77 - $6.67 $74,402 - $104,038	-15,598 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$3.34 - $5.56 $3,246 - $5,404	-972 Reduced 5.87%	15,598 $72,000
Q4 2021 Feb 14, 2022	BUY	$4.81 - $11.92 $79,701 - $197,514	16,570 New	16,570 $83,000
Q3 2019 Nov 14, 2019	SELL	$34.47 - $47.53 $295,752 - $407,807	-8,580 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$40.1 - $52.33 $15,639 - $20,408	390 Added 4.76%	8,580 $399,000
Q1 2019 May 13, 2019	BUY	$40.11 - $53.57 $328,500 - $438,738	8,190 New	8,190 $329,000
Q4 2017 Feb 09, 2018	SELL	$43.47 - $67.43 $613,361 - $951,437	-14,110 Closed	0 $0
Q3 2017 Nov 08, 2017	BUY	$43.8 - $52.77 $618,018 - $744,584	14,110	14,110 $707,000

206

128M

1.67M

930K

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $156M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.